News & Events

October 2025 · London, UK — A new study led by researchers at University College London (UCL) and Great Ormond Street Hospital has confirmed the long-term safety and efficacy of gene therapy for tre...

October 2025 · Worcester, Massachusetts — UMass Chan Medical School announced a five-year partnership with Makerere University and Mbarara University of Science and Technology in Uganda to strengthe...

October 2025 — Cambridge, MA — A team of scientists at the Massachusetts Institute of Technology (MIT) has developed a new system that allows researchers to precisely dial up or down the expression ...

October 2025 — Indianapolis, IN / Redwood City, CA — Eli Lilly and Company announced the acquisition of Adverum Biotechnologies in a deal valued at up to USD 262 million, strengthening Lilly’s stra...

October 2025 · Irving, Texas — McKesson Corporation, one of the world’s leading healthcare service and distribution companies, has released its latest industry report showing that while cell and ge...

An international research collaboration between UCLA, University College London (UCL), and Great Ormond Street Hospital has achieved a breakthrough in treating a fatal childhood immune disorder, adeno...

October 10, 2025 — Washington, D.C. — The U.S. Food and Drug Administration (FDA) has issued a new safety update for Carvykti (ciltacabtagene autoleucel), a CAR-T cell therapy co-developed by Johnso...

Brussels, July 7, 2025 — The European Commission and PIC/S (Pharmaceutical Inspection Co-operation Scheme) have jointly released the draft “GMP Annex 22: Artificial Intelligence (AI)”, launching a ...

The U.S. Food and Drug Administration (FDA) recently issued an important announcement stating it will pause new clinical trial applications led by U.S. institutions that involve sending cells from U.S...

October 6, 2025 — San Francisco, USA – AstraZeneca announced a strategic collaboration and licensing agreement with Algen Biotechnologies, a U.S.-based biotech company specializing in AI-driven gene...

Researchers from University College London (UCL) and the University of Oxford have developed remote-controlled synthetic cells capable of delivering therapeutic proteins directly within the body. Thes...

Allogenica, a biotechnology company based in Lyon, has secured €2.5 million in funding from the French government’s France 2030 strategic investment program. The grant will accelerate the industrial...